Cargando…

How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes

BACKGROUND: In breast cancer patients body image (BI) is a crucial aspect of quality of life (QoL). This study examined the postoperative impact of different surgical approaches on long-term BI analyzing real-world data to guide pre- and postoperative patient care and preserve QoL. METHODS: EORTC QL...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshar-Bakshloo, Melissa, Albers, Sarah, Richter, Chiara, Berninger, Ottilia, Blohmer, Jens-Uwe, Roehle, Robert, Speiser, Dorothee, Karsten, Maria Margarete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375629/
https://www.ncbi.nlm.nih.gov/pubmed/37507687
http://dx.doi.org/10.1186/s12885-023-11172-y
_version_ 1785079074983510016
author Afshar-Bakshloo, Melissa
Albers, Sarah
Richter, Chiara
Berninger, Ottilia
Blohmer, Jens-Uwe
Roehle, Robert
Speiser, Dorothee
Karsten, Maria Margarete
author_facet Afshar-Bakshloo, Melissa
Albers, Sarah
Richter, Chiara
Berninger, Ottilia
Blohmer, Jens-Uwe
Roehle, Robert
Speiser, Dorothee
Karsten, Maria Margarete
author_sort Afshar-Bakshloo, Melissa
collection PubMed
description BACKGROUND: In breast cancer patients body image (BI) is a crucial aspect of quality of life (QoL). This study examined the postoperative impact of different surgical approaches on long-term BI analyzing real-world data to guide pre- and postoperative patient care and preserve QoL. METHODS: EORTC QLQ-BR23 BI scores were collected electronically in 325 breast cancer patients within routine clinical care for a duration of 41.5 months (11/17/2016 – 4/30/2020) at predefined time points preoperatively and repeatedly up to two years after breast-conserving surgery (BCS) (n = 212), mastectomy alone (M) (n = 27) or mastectomy with immediate breast reconstruction (MIBR) (n = 86). Higher scores indicated better BI. A linear mixed regression model was used to analyze the impact of BCS, M and MIBR, as well as non-surgical therapies on BI at treatment initiation and over time. RESULTS: BI scores deteriorated by 5 points (95%-confidence interval (CI) -8.94 to -1.57, p≈0.005) immediately after BCS, by 7 points (95%-CI -12.13 to -1.80, p≈0.008) after MIBR and by 19 points (95%-CI -27.34 to -10.34, p < 0.001) after M. The change over time after BCS (+ 0.10 points per week, 95%-CI -0.17 to 0.38), MIBR (-0.07 points per week, 95%-CI -0.35 to 0.20) and M (+ 0.14 points per week, 95%-CI -0.19 to 0.48) were not statistically significant (each p > 0.05). At treatment initiation chemotherapy was associated with a 22-point decline (95%-CI -25.39 to -17.87, p < 0.001) in BI score, while radiotherapy was associated with a 5-point increase (95%-CI 1.74 to 9.02, p≈0.004). However, over time chemotherapy was associated with a score recovery (+ 0.28 points per week, 95%-CI 0.19 to 0.37, p < 0.001), whereas for radiotherapy a trend towards BI deterioration was observed (-0.11 points per week, 95%-CI -0.23 to 0.02, p≈0.101). CONCLUSIONS: Breast cancer surgery negatively affects BI. BCS and MIBR presumably harm BI less than M in the early postoperative period. Our data suggests BI to be deteriorating in the long term after MIBR while improving after BCS or M. Radiotherapy seems to have an additional negative long-term impact on BI. These findings should be confirmed in further studies to enable evidence-based patient information as part of preoperative shared decision-making and postoperative patient care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11172-y.
format Online
Article
Text
id pubmed-10375629
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103756292023-07-29 How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes Afshar-Bakshloo, Melissa Albers, Sarah Richter, Chiara Berninger, Ottilia Blohmer, Jens-Uwe Roehle, Robert Speiser, Dorothee Karsten, Maria Margarete BMC Cancer Research BACKGROUND: In breast cancer patients body image (BI) is a crucial aspect of quality of life (QoL). This study examined the postoperative impact of different surgical approaches on long-term BI analyzing real-world data to guide pre- and postoperative patient care and preserve QoL. METHODS: EORTC QLQ-BR23 BI scores were collected electronically in 325 breast cancer patients within routine clinical care for a duration of 41.5 months (11/17/2016 – 4/30/2020) at predefined time points preoperatively and repeatedly up to two years after breast-conserving surgery (BCS) (n = 212), mastectomy alone (M) (n = 27) or mastectomy with immediate breast reconstruction (MIBR) (n = 86). Higher scores indicated better BI. A linear mixed regression model was used to analyze the impact of BCS, M and MIBR, as well as non-surgical therapies on BI at treatment initiation and over time. RESULTS: BI scores deteriorated by 5 points (95%-confidence interval (CI) -8.94 to -1.57, p≈0.005) immediately after BCS, by 7 points (95%-CI -12.13 to -1.80, p≈0.008) after MIBR and by 19 points (95%-CI -27.34 to -10.34, p < 0.001) after M. The change over time after BCS (+ 0.10 points per week, 95%-CI -0.17 to 0.38), MIBR (-0.07 points per week, 95%-CI -0.35 to 0.20) and M (+ 0.14 points per week, 95%-CI -0.19 to 0.48) were not statistically significant (each p > 0.05). At treatment initiation chemotherapy was associated with a 22-point decline (95%-CI -25.39 to -17.87, p < 0.001) in BI score, while radiotherapy was associated with a 5-point increase (95%-CI 1.74 to 9.02, p≈0.004). However, over time chemotherapy was associated with a score recovery (+ 0.28 points per week, 95%-CI 0.19 to 0.37, p < 0.001), whereas for radiotherapy a trend towards BI deterioration was observed (-0.11 points per week, 95%-CI -0.23 to 0.02, p≈0.101). CONCLUSIONS: Breast cancer surgery negatively affects BI. BCS and MIBR presumably harm BI less than M in the early postoperative period. Our data suggests BI to be deteriorating in the long term after MIBR while improving after BCS or M. Radiotherapy seems to have an additional negative long-term impact on BI. These findings should be confirmed in further studies to enable evidence-based patient information as part of preoperative shared decision-making and postoperative patient care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11172-y. BioMed Central 2023-07-28 /pmc/articles/PMC10375629/ /pubmed/37507687 http://dx.doi.org/10.1186/s12885-023-11172-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Afshar-Bakshloo, Melissa
Albers, Sarah
Richter, Chiara
Berninger, Ottilia
Blohmer, Jens-Uwe
Roehle, Robert
Speiser, Dorothee
Karsten, Maria Margarete
How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
title How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
title_full How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
title_fullStr How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
title_full_unstemmed How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
title_short How breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
title_sort how breast cancer therapies impact body image – real-world data from a prospective cohort study collecting patient-reported outcomes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375629/
https://www.ncbi.nlm.nih.gov/pubmed/37507687
http://dx.doi.org/10.1186/s12885-023-11172-y
work_keys_str_mv AT afsharbakshloomelissa howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT alberssarah howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT richterchiara howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT berningerottilia howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT blohmerjensuwe howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT roehlerobert howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT speiserdorothee howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes
AT karstenmariamargarete howbreastcancertherapiesimpactbodyimagerealworlddatafromaprospectivecohortstudycollectingpatientreportedoutcomes